Last updated: 11/03/2018 19:26:08

Prevalence of patients infected with CCR5-tropic HIV-1 in Korea

GSK study ID
116696
See study documents
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Prevalence of patients infected with CCR5-tropic HIV-1 in Korea
Trial description: Cross sectional study
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

prevalence of CCR5 in HIV patients

Timeframe: NA

Secondary outcomes:

Predicting factors for CCR5-tropic HIV

Timeframe: NA

Duration of viral suppression

Timeframe: NA

Interventions:
  • Other: NA
    • Enrollment:
    308
    Primary completion date:
    Not applicable
    Observational study model:
    Other
    Time perspective:
    Cross-sectional
    Clinical publications:
    Not applicable
    Medical condition
    Infection, Human Immunodeficiency Virus
    Product
    maraviroc
    Collaborators
    Not applicable
    Study date(s)
    April 2013 to January 2015
    Type
    Observational
    Phase
    Not applicable

    Participation criteria

    Sex
    Female & Male
    Age
    20+ years
    Accepts healthy volunteers
    none
    • Subjects infected with HIV
    • older than 20 years old
    • Subjects who do not need antiviral treatment
    Inclusion and exclusion criteria
    Inclusion criteria:
    • Subjects infected with HIV
    • older than 20 years old
    • who need antiviral treatment
    • who signed informed consent
    Exclusion criteria:
    • Subjects who do not need antiviral treatment

    Trial location(s)

    This study does not involve prospective enrollment of participants.

    Study documents

    Scientific result summary
    Available language(s): English
    Download document(s)

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    Not applicable
    Actual study completion date
    2015-12-01

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website